By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kite Pharma, Inc. 

2225 Colorado Avenue

Santa Monica  California  90404  U.S.A.
Phone: 301-824-9999 Fax: n/a


Company News
U.S. Patent Office To Confirm Kite Pharma (KITE)’s Seminal Eshhar CAR-T Patent 6/28/2017 10:28:03 AM
A Look at the Deaths That Plagued Juno (JUNO) and Kite Pharma (KITE)'s CAR-T Trials 6/27/2017 6:42:12 AM
Tiny Bob Langer-Backed Kite Pharma (KITE) Files For $86 Million IPO 6/27/2017 6:01:35 AM
Kite Pharma (KITE) Reports 73 Percent Of Patients Achieved MRD Negative Complete Remission In Updated Analysis From Phase I ZUMA-3 CAR-T Trial Of KTE-C19 In Adult Patients With High Burden Relapsed/Refractory Acute Lymphoblastic Leukemia 6/5/2017 8:47:48 AM
Kite Pharma (KITE) Catches Up With Novartis AG (NVS) As CAR-T BLA Gets Priority Review Status 5/30/2017 5:50:16 AM
Kite Pharma (KITE) Receives FDA Priority Review For Axicabtagene Ciloleucel 5/26/2017 11:21:45 AM
Kite Pharma (KITE) Announces Presentations On Its Lead CAR-T Therapy Development Program At The 2017 ASCO Annual Meeting 5/18/2017 8:24:02 AM
Kite Pharma (KITE) Stock Plunges After Report of Patient Death in CAR-T Clinical Trial 5/8/2017 7:58:31 AM
Kite Pharma (KITE) Reports First Quarter Financial Results 5/8/2017 7:47:57 AM
Kite Pharma (KITE) To Report First Quarter 2017 Financial Results On May 8, 2017 5/1/2017 7:41:52 AM